InsiderTrades

Form 4 for MIRM Mirum Pharmaceuticals, Inc.

Accepted 2025-06-02 00:00:00 ET · period of report 2025-05-29 · accession 0001415889-25-015303 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-06-02 2025-05-29 MIRM Brege Laura Dir M - OptEx — +5,703 15.7K +57% —
DM 2025-06-02 2025-05-29 MIRM Brege Laura Dir A - Grant $0.00 +10.2K 6,268 New $0
D 2025-06-02 2025-05-29 MIRM Brege Laura Dir M - OptEx $0.00 -5,703 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-05-29 M A 5,703 — 15,703 D — — (F1) Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer).
2 Derivative Deferred Stock Units 2025-05-29 A A 3,977 $0.00 3,977 D — · — to — 3,977 Common Stock (F4) Each deferred stock unit represents a contingent right to receive one share of the Issuer's common stock and will vest on the first anniversary of the grant date, provided that it will in any case be fully vested on the date of the Issuer's 2026 annual stockholder meeting. Each vested deferred stock unit will be paid out in the Issuer's common stock upon the earliest to occur of (i) a change in control of the Issuer and (ii) within 60 days following separation from service with the Issuer.
3 Derivative Stock Option (right to buy) 2025-05-29 A A 6,268 $0.00 6,268 D $44.00 · — to 2035-05-28 6,268 Common Stock (F3) The shares vest on the first anniversary of the grant date, provided that the option will in any case be fully vested on the date of the Issuer's 2026 annual stockholder meeting.
4 Derivative Restricted Stock Units 2025-05-29 M D 5,703 $0.00 0 D — · — to — 5,703 Common Stock (F1) Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer). (F2) The restricted stock unit vests on the first anniversary of the grant date, provided that it will in any case be fully vested on the date of the Issuer's 2025 annual stockholder meeting.